<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The objective of this study was to analyse the prevalence and characteristics of the main clinical and immunological manifestations at the <z:hpo ids='HP_0003674'>onset</z:hpo> and during the evolution of the disease in a cohort of patients from Latin America (mainly of mestizo origin) and to compare the Latin American with the European patients </plain></SENT>
<SENT sid="1" pm="."><plain>Clinical and serological characteristics of 100 APS patients from Mexico and Ecuador were collected in a protocol form that was identical to that used to study the ;Euro-<z:chebi fb="0" ids="16247">Phospholipid</z:chebi>' cohort </plain></SENT>
<SENT sid="2" pm="."><plain>The cohort consisted of 93 female patients (93.0%) and seven (7.0%) male patients </plain></SENT>
<SENT sid="3" pm="."><plain>There were 91 mestizos (91.0%), seven whites (7.0%) and two Amerindians (2.0%) </plain></SENT>
<SENT sid="4" pm="."><plain>The most common manifestations were <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> (40.0%), <z:hpo ids='HP_0002076'>migraine</z:hpo> (35.0%), inferior extremity <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> (32.0%), <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> (28.0%) and <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo> (20.0%) </plain></SENT>
<SENT sid="5" pm="."><plain>Several clinical manifestations were more prevalent in Latin American than in European patients and they included mainly neurological (<z:hpo ids='HP_0002076'>migraine</z:hpo>, <z:hpo ids='HP_0010534'>transient global amnesia</z:hpo>, <z:hpo ids='HP_0011009'>acute</z:hpo> ischemic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo>, <z:hpo ids='HP_0100576'>amaurosis fugax</z:hpo>) and cutaneous (<z:hpo ids='HP_0000965'>livedo reticularis</z:hpo>, <z:mp ids='MP_0001209'>skin ulcerations</z:mp>, superficial cutaneous <z:mp ids='MP_0001651'>necrosis</z:mp>, multiple subungual splinter <z:mp ids='MP_0001914'>hemorrhages</z:mp>) manifestations as well as <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The APS has a wide variety of clinical and immunological manifestations at the <z:hpo ids='HP_0003674'>onset</z:hpo> and during the evolution of the disease and the ethnic origin in addition to environmental and socioeconomic factors can modify the disease expression </plain></SENT>
</text></document>